195 related articles for article (PubMed ID: 36715504)
1. IFN-γ-STAT1-mediated NK2R expression is involved in the induction of antitumor effector CD8
Shen W; Wang X; Xiang H; Shichi S; Nakamoto H; Kimura S; Sugiyama K; Taketomi A; Kitamura H
Cancer Sci; 2023 May; 114(5):1816-1829. PubMed ID: 36715504
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide signaling activates dendritic cell-mediated type 1 immune responses through neurokinin-2 receptor.
Kitamura H; Kobayashi M; Wakita D; Nishimura T
J Immunol; 2012 May; 188(9):4200-8. PubMed ID: 22474018
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ elevates airway hyper-responsiveness via up-regulation of neurokinin A/neurokinin-2 receptor signaling in a severe asthma model.
Kobayashi M; Ashino S; Shiohama Y; Wakita D; Kitamura H; Nishimura T
Eur J Immunol; 2012 Feb; 42(2):393-402. PubMed ID: 22105467
[TBL] [Abstract][Full Text] [Related]
4. IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells.
Xiang H; Toyoshima Y; Shen W; Wang X; Okada N; Kii S; Sugiyama K; Nagato T; Kobayashi H; Ikeo K; Hashimoto S; Tanino M; Taketomi A; Kitamura H
Cancer Sci; 2022 Aug; 113(8):2513-2525. PubMed ID: 35561088
[TBL] [Abstract][Full Text] [Related]
5. Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy.
Ohno Y; Toyoshima Y; Yurino H; Monma N; Xiang H; Sumida K; Kaneumi S; Terada S; Hashimoto S; Ikeo K; Homma S; Kawamura H; Takahashi N; Taketomi A; Kitamura H
Cancer Sci; 2017 Oct; 108(10):1959-1966. PubMed ID: 28746799
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory impact of IFN-γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways.
Ramana CV; DeBerge MP; Kumar A; Alia CS; Durbin JE; Enelow RI
Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(7):L650-7. PubMed ID: 25617378
[TBL] [Abstract][Full Text] [Related]
8. T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.
Liu W; Guo W; Shen L; Chen Z; Luo Q; Luo X; Feng G; Shu Y; Gu Y; Xu Q; Sun Y
Oncotarget; 2017 Jan; 8(5):7586-7597. PubMed ID: 27935860
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors.
Nagato T; Lee YR; Harabuchi Y; Celis E
Clin Cancer Res; 2014 Mar; 20(5):1223-34. PubMed ID: 24389326
[TBL] [Abstract][Full Text] [Related]
10. Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.
Lu L; Xu X; Zhang B; Zhang R; Ji H; Wang X
J Transl Med; 2014 Feb; 12():36. PubMed ID: 24502656
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.
Zimmerman M; Yang D; Hu X; Liu F; Singh N; Browning D; Ganapathy V; Chandler P; Choubey D; Abrams SI; Liu K
PLoS One; 2010 Nov; 5(11):e14076. PubMed ID: 21124930
[TBL] [Abstract][Full Text] [Related]
12. Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response.
Hannesdóttir L; Tymoszuk P; Parajuli N; Wasmer MH; Philipp S; Daschil N; Datta S; Koller JB; Tripp CH; Stoitzner P; Müller-Holzner E; Wiegers GJ; Sexl V; Villunger A; Doppler W
Eur J Immunol; 2013 Oct; 43(10):2718-29. PubMed ID: 23843024
[TBL] [Abstract][Full Text] [Related]
13. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice.
Sun R; Park O; Horiguchi N; Kulkarni S; Jeong WI; Sun HY; Radaeva S; Gao B
Hepatology; 2006 Oct; 44(4):955-66. PubMed ID: 17006930
[TBL] [Abstract][Full Text] [Related]
14. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
Guo Z; Wang H; Meng F; Li J; Zhang S
J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1.
Jaruga B; Hong F; Kim WH; Gao B
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1044-52. PubMed ID: 15246962
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G
J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
[TBL] [Abstract][Full Text] [Related]
17. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
18. A Human STAT1 Gain-of-Function Mutation Impairs CD8
Qian W; Miner CA; Ingle H; Platt DJ; Baldridge MT; Miner JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315996
[TBL] [Abstract][Full Text] [Related]
19. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression.
Aruga A; Aruga E; Cameron MJ; Chang AE
J Leukoc Biol; 1997 Apr; 61(4):507-16. PubMed ID: 9103238
[TBL] [Abstract][Full Text] [Related]
20. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta.
Ngoi SM; Tovey MG; Vella AT
J Immunol; 2008 Dec; 181(11):7670-80. PubMed ID: 19017955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
